Literature DB >> 26489875

Changes in induction methods have not influenced cesarean section rates among women with induced labor.

Malin Dögl1,2, Eszter Vanky2,3, Runa Heimstad2,3.   

Abstract

INTRODUCTION: Induction of labor has become more common in most countries during the last decade. We have compared methods and routines of labor induction as practiced in Norway in 2003 and 2013, and surveyed practices with regard to induction of labor without a medical indication in 2013.
MATERIAL AND METHODS: A telephone interview with all delivery units in Norway was conducted in 2003. Data on preferred induction methods, use of prostaglandin, dosages, dose intervals and routes of administration were collected. In 2013, the same questionnaire was used, with additional questions on induction of labor without a medical indication. Data on overall cesarean section and induction rates were obtained from the Medical Birth Registry of Norway.
RESULTS: From 2003 to 2013 the induction rate increased by 62% and the cesarean section rate by 6%. The cesarean section rate in women with induced labor remained stable at 17.1 and 17.4%, respectively. In 2003, 31 of 43 hospitals used dinoprostone for cervical ripening and induction. In 2013, 34 of 39 hospitals used misoprostol. A cervical balloon was used in three of 43 hospitals in 2003 compared with 31 of 39 in 2013. All but one hospital induced labor without a strict medical indication in 2013.
CONCLUSION: The preferred methods for induction of labor changed within a decade to the use of misoprostol and cervical balloon. Induction of labor without strict medical indications is widely practiced. The changed induction methods have not influenced the cesarean section rates in women with induced labors.
© 2015 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Induction of labor; Norway; cervical balloon; cesarean section; dinoprostone; misoprostol

Mesh:

Substances:

Year:  2015        PMID: 26489875     DOI: 10.1111/aogs.12809

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  5 in total

1.  Cesarean delivery in Norwegian nulliparous women with singleton cephalic term births, 1967-2020: a population-based study.

Authors:  Yeneabeba Tilahun Sima; Rolv Skjærven; Liv Grimstvedt Kvalvik; Nils-Halvdan Morken; Kari Klungsøyr; Linn Marie Sørbye
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-18       Impact factor: 3.105

2.  Temporal Trends in Late Preterm and Early Term Birth Rates in 6 High-Income Countries in North America and Europe and Association With Clinician-Initiated Obstetric Interventions.

Authors:  Jennifer L Richards; Michael S Kramer; Paromita Deb-Rinker; Jocelyn Rouleau; Laust Mortensen; Mika Gissler; Nils-Halvdan Morken; Rolv Skjærven; Sven Cnattingius; Stefan Johansson; Marie Delnord; Siobhan M Dolan; Naho Morisaki; Suzanne Tough; Jennifer Zeitlin; Michael R Kramer
Journal:  JAMA       Date:  2016-07-26       Impact factor: 56.272

3.  A comparison of misoprostol vaginal insert and misoprostol vaginal tablets for induction of labor in nulliparous women: a retrospective cohort study.

Authors:  Kjersti Engen Marsdal; Ingvil Krarup Sørbye; Lise C Gaudernack; Mirjam Lukasse
Journal:  BMC Pregnancy Childbirth       Date:  2018-01-05       Impact factor: 3.007

4.  Elective induction of labor: A prospective observational study.

Authors:  Malin Dögl; Pål Romundstad; Line Dahlgaard Berntzen; Oliv Camilla Fremgaarden; Katrine Kirial; Anne Molne Kjøllesdal; Benedicte S Nygaard; Line Robberstad; Thorbjørn Steen; Christian Tappert; Cecilie Fredvik Torkildsen; Magdalena R Vaernesbranden; Alexander Vietheer; Runa Heimstad
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

5.  Intracervical Foley catheter balloon versus dinoprostone insert for induction cervical ripening: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Lixia Zhu; Cong Zhang; Fang Cao; Qin Liu; Xing Gu; Jianhao Xu; Jianqing Li
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.